Boundless Bio Financials
| BOLD Stock | USD 1.23 0.05 4.24% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.78 | 17.08 |
|
|
Investors should never underestimate Boundless Bio's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Boundless Bio's cash flow, debt, and profitability to make informed and accurate decisions about investing in Boundless Bio Common.
Net Income |
|
Boundless | Select Account or Indicator | Build AI portfolio with Boundless Stock |
Understanding current and past Boundless Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Boundless Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Boundless Bio's assets may result in an increase in income on the income statement.
Please note, the presentation of Boundless Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Boundless Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Boundless Bio's management manipulating its earnings.
Boundless Bio Stock Summary
Boundless Bio competes with Q32 Bio, NextCure, Plus Therapeutics, Intensity Therapeutics, and Iterum Therapeutics. Audentes Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases caused by single gene defects. Audentes Therapeutics, Inc. was founded in 2012 and is headquartered in San Francisco, California. Audentes Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 207 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US10170A1007 |
| Business Address | 10955 Alexandria Way, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | boundlessbio.com |
| Phone | 858 766 9912 |
| Currency | USD - US Dollar |
Boundless Bio Key Financial Ratios
| Return On Equity | -0.45 | ||||
| EBITDA | (64.28 M) | ||||
| Net Income | (65.36 M) | ||||
| Cash Per Share | 7.68 X | ||||
| Debt To Equity | 0.08 % |
Boundless Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Boundless Bio's current stock value. Our valuation model uses many indicators to compare Boundless Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Boundless Bio competition to find correlations between indicators driving Boundless Bio's intrinsic value. More Info.Boundless Bio Common is rated third in return on equity category among its peers. It is number one stock in return on asset category among its peers . At present, Boundless Bio's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Boundless Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Boundless Bio Common Systematic Risk
Boundless Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Boundless Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Boundless Bio Common correlated with the market. If Beta is less than 0 Boundless Bio generally moves in the opposite direction as compared to the market. If Boundless Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Boundless Bio Common is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Boundless Bio is generally in the same direction as the market. If Beta > 1 Boundless Bio moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Boundless Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Boundless Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Boundless Bio growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Boundless Bio January 6, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Boundless Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Boundless Bio Common. We use our internally-developed statistical techniques to arrive at the intrinsic value of Boundless Bio Common based on widely used predictive technical indicators. In general, we focus on analyzing Boundless Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Boundless Bio's daily price indicators and compare them against related drivers.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 15.34 | |||
| Value At Risk | (4.84) | |||
| Potential Upside | 5.69 |
Complementary Tools for Boundless Stock analysis
When running Boundless Bio's price analysis, check to measure Boundless Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boundless Bio is operating at the current time. Most of Boundless Bio's value examination focuses on studying past and present price action to predict the probability of Boundless Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boundless Bio's price. Additionally, you may evaluate how the addition of Boundless Bio to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |